The effect of cardiac hypertrophy on the coronary collateral circulation. Harrison DG, Barnes DH, Hiratzka LF, Eastham CL, Kerber RE, Marcus ML (1985) Circulation 71: 1135-45 Cardiovascular effects of noncardiovascular drugs. Raj SR, Stein CM, Saavedra PJ, Roden DM (2009) Circulation 120: 1123-32 Insights into (the interstitium of) degenerative aortic valve disease. Merryman WD (2008) J Am Coll Cardiol 51: 1415; author reply 1416 Potential drug targets for calcific aortic valve disease. Hutcheson JD, Aikawa E, Merryman WD (2014) Nat Rev Cardiol 11: 218-31 Serotonin receptors and heart valve disease--it was meant 2B. Hutcheson JD, Setola V, Roth BL, Merryman WD (2011) Pharmacol Ther 132: 146-57 Cadherin-11 regulates cell-cell tension necessary for calcific nodule formation by valvular myofibroblasts. Hutcheson JD, Chen J, Sewell-Loftin MK, Ryzhova LM, Fisher CI, Su YR, Merryman WD (2013) Arterioscler Thromb Vasc Biol 33: 114-20 Calcific aortic valve disease: a consensus summary from the Alliance of Investigators on Calcific Aortic Valve Disease. Yutzey KE, Demer LL, Body SC, Huggins GS, Towler DA, Giachelli CM, Hofmann-Bowman MA, Mortlock DP, Rogers MB, Sadeghi MM, Aikawa E (2014) Arterioscler Thromb Vasc Biol 34: 2387-93 Intracellular Ca(2+) accumulation is strain-dependent and correlates with apoptosis in aortic valve fibroblasts. Hutcheson JD, Venkataraman R, Baudenbacher FJ, Merryman WD (2012) J Biomech 45: 888-94 Mechano-potential etiologies of aortic valve disease. David Merryman W (2010) J Biomech 43: 87-92 Computed tomography-derived cardiovascular risk markers, incident cardiovascular events, and all-cause mortality in nondiabetics: the Multi-Ethnic Study of Atherosclerosis. Yeboah J, Carr JJ, Terry JG, Ding J, Zeb I, Liu S, Nasir K, Post W, Blumenthal RS, Budoff MJ (2014) Eur J Prev Cardiol 21: 1233-41
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.